What are the side effects of Aceminid?
Asciminib (scemblix/asciminib) is a kinase inhibitor used to treat adult patients with the following: Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in the chronic phase (CP), previously treated with two or more tyrosine kinase inhibitors (TKIs) and T315Imutated chronic myelogenous leukemia Ph+chronic myelogenous leukemia.

Common side effects for patients with Philadelphia chromosome-positive chronic myelogenous leukemia include decreased platelet count (46%) and increased triglycerides (44%
Common side effects in patients with T315Imutated chronic myelogenous leukemia include increased alanine aminotransferase (48%), increased potassium (48%), and increased triglycerides (46% ), increased lipase (46%), decreased hemoglobin (44%), decreased neutrophil count (44%), musculoskeletal pain (42%), decreased lymphocyte count (42%), decreased phosphate (40%), increased uric acid (40%), aspartate Elevated transaminases (35%), decreased calcium correction (33%), fatigue (31%), increased creatinine (31%) , elevated amylase (29%), nausea (27%), rash (27%), decreased platelet count (25%), elevated bilirubin (23%), diarrhea (21%), vomiting (19%), headache (19%), Joint pain (17%), cough (15%), bleeding (15%), increased cholesterol 15%, itching (< /span>13%), hypertension (13%), upper respiratory tract infection (13%), increased alkaline phosphate (13%), etc. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)